PILUSO, ALESSIA
 Distribuzione geografica
Continente #
NA - Nord America 3.381
EU - Europa 2.100
AS - Asia 1.083
SA - Sud America 153
AF - Africa 36
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.775
Nazione #
US - Stati Uniti d'America 3.345
RU - Federazione Russa 698
PL - Polonia 643
SG - Singapore 308
CN - Cina 248
HK - Hong Kong 167
IE - Irlanda 161
VN - Vietnam 149
SE - Svezia 146
IT - Italia 134
BR - Brasile 122
FI - Finlandia 86
KR - Corea 80
DE - Germania 70
FR - Francia 46
GB - Regno Unito 44
IN - India 33
UA - Ucraina 23
CA - Canada 22
JP - Giappone 22
AU - Australia 21
ID - Indonesia 18
AR - Argentina 14
BE - Belgio 14
TR - Turchia 14
JO - Giordania 13
CI - Costa d'Avorio 11
ZA - Sudafrica 11
NL - Olanda 9
IQ - Iraq 8
MX - Messico 8
BD - Bangladesh 5
EC - Ecuador 5
EG - Egitto 5
CO - Colombia 4
RO - Romania 4
VE - Venezuela 4
HN - Honduras 3
LT - Lituania 3
PH - Filippine 3
AE - Emirati Arabi Uniti 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
ES - Italia 2
HU - Ungheria 2
MA - Marocco 2
MT - Malta 2
PY - Paraguay 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
TW - Taiwan 2
UZ - Uzbekistan 2
AL - Albania 1
AM - Armenia 1
AZ - Azerbaigian 1
BH - Bahrain 1
CR - Costa Rica 1
EU - Europa 1
IL - Israele 1
JM - Giamaica 1
KE - Kenya 1
KZ - Kazakistan 1
LV - Lettonia 1
MD - Moldavia 1
MY - Malesia 1
MZ - Mozambico 1
NG - Nigeria 1
NO - Norvegia 1
PE - Perù 1
PT - Portogallo 1
RS - Serbia 1
SA - Arabia Saudita 1
SC - Seychelles 1
SI - Slovenia 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
Totale 6.775
Città #
Santa Clara 782
Warsaw 639
Ashburn 376
Fairfield 275
Singapore 198
Dublin 161
Chandler 160
San Jose 147
Woodbridge 136
Hong Kong 134
Seattle 132
Beijing 118
Cambridge 111
Wilmington 109
Houston 100
Ann Arbor 98
Seoul 77
The Dalles 68
Altamura 58
Buffalo 56
Lawrence 50
Ho Chi Minh City 45
Princeton 45
Helsinki 43
Lauterbourg 36
Bremen 34
Florence 34
Jacksonville 27
Hanoi 26
Mumbai 26
Council Bluffs 25
Boston 23
Los Angeles 23
Medford 23
New York 22
Boardman 20
Dong Ket 20
Melbourne 20
Shanghai 20
Tokyo 19
Munich 18
San Diego 16
Brussels 14
Dallas 12
Jakarta 12
Abidjan 11
Falls Church 11
London 11
São Paulo 10
Izmir 9
Norwalk 9
Brooklyn 8
Clifton 7
Montreal 7
Moscow 7
Old Bridge 7
Phoenix 7
Andover 6
Johannesburg 6
Redondo Beach 6
Turku 6
Frankfurt am Main 5
Vancouver 5
Washington 5
Atlanta 4
Avigliano 4
Baghdad 4
Chicago 4
Cluj-Napoca 4
Fortaleza 4
Haiphong 4
Hải Dương 4
New Delhi 4
Orem 4
Stockholm 4
Toronto 4
Biên Hòa 3
Da Nang 3
Denver 3
Ferriere 3
Guayaquil 3
Hillsboro 3
Istanbul 3
Manaus 3
Portsmouth 3
Redmond 3
Rome 3
Salt Lake City 3
Thái Bình 3
Vũng Tàu 3
Amsterdam 2
Aparecida de Goiânia 2
Asunción 2
Bastia umbra 2
Brasília 2
Bratislava 2
Budapest 2
Bắc Ninh 2
Campo Grande 2
Caracas 2
Totale 4.841
Nome #
Hepatitis C Virus infection in the immunocompromised host: a complex scenario with variable clinical impact 323
Role of MicroRNA Profile Modifications in Hepatitis C Virus-Related Mixed Cryoglobulinemia 316
Evaluation of the prognostic value of liver stiffness in patients with hepatitis C virus treated with triple or dual antiviral therapy: A prospective pilot study 313
Impact of immunogenetic IL28B polymorphism on natural outcome of HCV infection. 262
Efficacy of low-dose rituximab for the treatment of mixed cryoglobulinemia vasculitis: Phase II clinical trial and systematic review 253
Assessment of free light chains in HCV-positive patients with mixed cryoglobulinaemia vasculitis undergoing rituximab treatment 242
Deregulation of microRNA expression in peripheral blood mononuclear cells from patients with HCV-related malignancies 223
Combined treatment with antiviral therapy and rituximab in patients with mixed cryoglobulinemia: review of the literature and report of a case using direct antiviral agents-based antihepatitis C virus therapy 222
A phase II, single-arm multicenter study of low-dose rituximab for refractory mixed cryoglobulinemia secondary to hepatitis C virus infection 217
Long-term effect of HCV eradication in patients with mixed cryoglobulinemia: A prospective, controlled, open-label, cohort study. 203
Host genetic determinants in HCV-related mixed cryoglobulinemia 198
Host genetic determinants in HCV-related mixed cryoglobulinemia 190
MicroRNA expression in hepatitis C virus-related malignancies: A brief review 188
Hepatitis C virus syndrome: A constellation of organ- and non-organ specific autoimmune disorders, B-cell non- Hodgkin's lymphoma, and cancer 182
Can BAFF promoter polymorphism be a predisposing condition for HCV-related mixed cryoglobulinemia? 174
Triple antiviral therapy in hepatitis C virus infection with or without mixed cryoglobulinaemia: A prospective, controlled pilot study. 170
HCV-related mixed cryoglobulinemia and BAFF promoter polymorphism 168
Hepatitis C virus-related mixed cryoglobulinemia: is genetics to blame? 168
microRNA PROFILE MODIFICATIONS IN HEPATITIS C VIRUS-RELATED MIXED CRYOGLOBULINEMIA 167
HBV and HCV chronic infection: Autoimmune manifestations and lymphoproliferation 162
Host genetic determinants in HCV-related mixed cryoglobulinemia 161
ETIOLOGICAL THERAPY IN HCV-RELATED MIXED CRYOGLOBULINEMIA SYNDROME: THE ROLE OF IL28B GENOTYPE AS PREDICTOR OF RESPONSE 160
Could the presence of Mixed Cryoglobulinemia influence the outcome of standard peg-IFN plus ribavirin anti-HCV therapy? 153
Virus-driven autoimmunity and lymphoproliferation: the example of HCV infection. 151
Genetic determinants in Hepatitis C Virus-associated mixed cryoglobulinemia: role of polymorphic variants of BAFF promoter and Fc-gamma receptors 148
HCV-related lymphatic and hepatic malignancies are associated with different microRNA expression patterns in PBMCs 146
Circadian Pattern of Serum Leptin and b-Endorphin Levels in Obese and Non Obese Women. 145
Response to IFN-based antiviral therapy and long term effect of HCV eradication in Mixed Cryoglobulinemia, with or without symptoms: a prospective, controlled, open-label, long term, cohort study 141
The role of the rs12979860 polymorphism of the interleukin-28b as predictor of spontaneus clearance of HCV infection in patients with hemophilia 136
VALUE OF IL28B GENOTYPING IN PATIENTS WITH HCV-RELATED MIXED CRYOGLOBULINEMIA: RESULTS OF A LARGE, PROSPECTIVE STUDY 133
HCV infection and carotid atherosclerosis: evidence in favour of a local viral action inside the plaque 132
Il polimorfismo dell'interleuchina 28B come predittore di risposta in pazienti con crioglobulinemia mista HCV-correlata 132
HCV AND lymphoma: Genetic and epigenetic factors 127
IL28B POLYMORPHISM AS PREDICTOR OF RESPONSE TO ANTI-HCV THERAPY IN HCV-RELATED MIXED CRYOGLOBULINEMIA SYNDROME 125
Hepatitis C-associated B-cell non-Hodgkin lymphomas: The emerging role of miRNA-26 120
Mixed cryoglobulinemia syndrome is a negative prognostic factor in the standard of care (Peg-IFN+ribavirin) anti-HCV therapy 119
IL28B polymorphism as predictor of response to anti-HCV terapy in HCV-related mixed cryoglobulinemia syndrome 115
Long-term outcome of HCV-related mixed cryoglobulinemia in patients achieving sustained viral sustained viral response (SVR) after antiviral therapy 111
Totale 6.796
Categoria #
all - tutte 17.400
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.400


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202157 0 0 0 0 0 0 0 0 0 0 29 28
2021/2022315 3 30 18 20 13 19 9 23 11 13 58 98
2022/2023766 70 126 40 74 61 142 99 44 80 1 21 8
2023/2024209 5 37 44 8 5 25 2 62 4 2 6 9
2024/20251.945 79 198 124 276 630 288 9 107 81 20 75 58
2025/20261.646 235 236 92 149 189 89 203 85 198 140 30 0
Totale 6.796